Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyDrug Reaction DataReferences

View all Images (17)

Primary hyperparathyroidism
Other Resources UpToDate PubMed

Primary hyperparathyroidism

Contributors: Joon B. Kim MD, Marilyn Augustine MD, Michael W. Winter MD
Other Resources UpToDate PubMed

Synopsis

Primary hyperparathyroidism is hyperfunction of the parathyroid glands resulting in overproduction of parathyroid hormone (PTH), which causes elevated blood calcium levels (see hypercalcemia). Primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, and parathyroid carcinoma (in rare cases).

High-risk populations include postmenopausal women and patients who have had chronic and serious calcium or vitamin D deficiency, have a rare genetic disease, have undergone radiation therapy, or have taken lithium.

The disorder is most prevalent in individuals between 50 and 60 years of age. Females are more frequently affected.

Patients are usually asymptomatic. Symptomatic patients have variable presentations. In mild cases, common symptoms include fatigue, lethargy, depression, muscle weakness, and muscle pain. In severe cases, symptoms include anorexia, nausea, vomiting, constipation, confusion, memory impairment, frequent urination, and bone thinning and fractures. Sustained hyperparathyroidism can lead to osteitis fibrosa cystica, forming cystlike tumors in the bones.

Complications are dependent on the long-term effects of insufficient calcium in a patient's bones and excessive calcium circulating in the bloodstream. Common complications include osteoporosis, kidney stones, cardiovascular disease, and hypoparathyroidism of the neonate in pregnant individuals with untreated hyperparathyroidism.

Treatment is dependent on the course of the disease and will vary depending on individual cases. Patients who are asymptomatic may not require any treatment and should be closely monitored by their physicians. Medications such as bisphosphonates may help with bone health, and estrogen therapy may benefit postmenopausal women. Patients with primary hyperparathyroidism due to familial hypocalciuric hypercalcemia may need parathyroidectomies.

Codes

ICD10CM:
E21.0 – Primary hyperparathyroidism

SNOMEDCT:
237653008 – Familial primary hyperparathyroidism
36348003 – Primary hyperparathyroidism

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

Drug Reaction Data

Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.

Subscription Required

References

Subscription Required

Last Reviewed:05/06/2019
Last Updated:08/05/2021
Copyright © 2023 VisualDx®. All rights reserved.
Primary hyperparathyroidism
A medical illustration showing key findings of Primary hyperparathyroidism (Asymptomatic) : Ca elevated
Imaging Studies image of Primary hyperparathyroidism - imageId=7902630. Click to open in gallery.  caption: '<span>Subchondral/subligamentous  bone resorption at the sacroiliac joints and pubic symphysis, compatible  with hyperparathyroidism. Note the presence of a peritoneal dialysis  catheter.</span>'
Subchondral/subligamentous bone resorption at the sacroiliac joints and pubic symphysis, compatible with hyperparathyroidism. Note the presence of a peritoneal dialysis catheter.
Copyright © 2023 VisualDx®. All rights reserved.